| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59651-602-30 | 59651-602 | HUMAN PRESCRIPTION DRUG | Deflazacort | Deflazacort | TABLET | ORAL | 20240209 | N/A | ANDA | ANDA217123 | Aurobindo Pharma Limited | DEFLAZACORT | 36 mg/1 | 30 TABLET in 1 BOTTLE (59651-602-30) |
| 59651-601-30 | 59651-601 | HUMAN PRESCRIPTION DRUG | Deflazacort | Deflazacort | TABLET | ORAL | 20240209 | N/A | ANDA | ANDA217123 | Aurobindo Pharma Limited | DEFLAZACORT | 30 mg/1 | 30 TABLET in 1 BOTTLE (59651-601-30) |
| 59651-600-30 | 59651-600 | HUMAN PRESCRIPTION DRUG | Deflazacort | Deflazacort | TABLET | ORAL | 20240209 | N/A | ANDA | ANDA217123 | Aurobindo Pharma Limited | DEFLAZACORT | 18 mg/1 | 30 TABLET in 1 BOTTLE (59651-600-30) |
| 59651-599-01 | 59651-599 | HUMAN PRESCRIPTION DRUG | Deflazacort | Deflazacort | TABLET | ORAL | 20240209 | N/A | ANDA | ANDA217123 | Aurobindo Pharma Limited | DEFLAZACORT | 6 mg/1 | 100 TABLET in 1 BOTTLE (59651-599-01) |